Smallest Ever System on a Chip for Health Monitoring

Movano Health's SoC is designed to monitor blood glucose, blood pressure & other chronic conditions.

Image credits: Movano

Movano Health, a pioneer in health technology, announced that following the successful results of its recent blood pressure clinical trial it will be holding in-person demonstrations of live waveforms at the 2024 CES Show in Las Vegas.

Designed to showcase Movano Health's System on a Chip (SoC) and illustrate the strategic ways this technology can be implemented to monitor multiple chronic conditions, these events will be an opportunity for prospective partners to experience the efficacy of the recent clinical trial results and, if desired, under NDA review the development roadmap.

"The response to our recent blood pressure clinical trial results has far exceeded our expectations and as we transition to the next phase of development including undergoing critical pivotal trials, we believe it is the right time to open up the conversation to potential partners," said Michael Leabman, CTO and Founder of Movano Health. "Our goal is to significantly accelerate the development and commercialization of this technology and help millions of people as quickly as possible."

During the recent trial, Movano Health's cuffless prototype showed a level of accuracy within the standards recognized by the FDA for blood pressure monitoring devices. The prototype achieved an overall mean absolute difference (MAD) of 5.9 mmHg, which is below the 7 mmHg MAD required per a standard for wearable, cuffless blood pressure measuring devices (IEEE1708a-2019). Movano Health is also evaluating AI-based individual calibration methods to further enhance the future performance of the device.

Read more: Blood Pressure Measuring E-Tattoo

Movano Health's ultra-compact System-on-a-Chip (SoC) measures just 4x6.7mm and is the culmination of five years of intensive research, centering on advanced mmWave Radio Frequency (RF) and AI technology, leading to 23 issued patents and 31 pending.

"Blood pressure monitoring will be a significant addition to the suite of analytes we currently offer in our recently launched product, the Evie Ring", said John Mastrototaro, CEO of Movano Health. "We are excited to continue to build a robust data collection and evaluation solution to help people take better care of their overall health."

About Movano Health  

Founded in 2018, Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. Featuring modern form factors, Movano Health's devices capture a comprehensive picture of a person's vital health information and uniquely translate the data into personalized and intelligent insights that empower consumers to live healthier and more balanced lives. Movano Health's end-to-end solutions will soon enable consumers and their healthcare professionals to utilize daily medical-grade data as a tool to proactively monitor and manage health outcomes.

Sam Draper
December 29, 2023

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Korean ECG Patch Gets FDA Clearance

Wellysis received clearance from the FDA to market its wearable electrocardiography (ECG) patch.

Companies That Are Fueling the Growth of Femtech Industry

When we talk about femtech, issues that come to mind are pregnancy and menstruation. But now...

Amazon Care to add mental health services

Amazon Care plans to expand its offering by including behavioral health services

Apple Watch Glucose Tracker Reaches Proof-Of-Concept

Apple reached the proof-of-concept stage of noninvasive blood glucose monitoring technology.
Discover more